Frankfurt
28.02.25
09:09 Uhr
0,428 Euro
-0,046
-9,70 %
-9,70 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.02. | Medicure, Inc.: Medicure Announces Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of Gateway Medical Pharmacy | 177 | ACCESS Newswire | WINNIPEG, MB / ACCESS Newswire / February 18, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals... ► Artikel lesen | |
| MEDICURE Aktie jetzt für 0€ handeln | |||||
| 18.02. | MEDICURE INC - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 26.11.24 | MEDICURE INC - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 26.11.24 | Medicure, Inc.: Medicure Reports Financial Results For Quarter Ended September 30, 2024 | 347 | ACCESS Newswire | WINNIPEG, MB / ACCESSWIRE / November 25, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals... ► Artikel lesen | |
| 26.11.24 | Medicure GAAP EPS of C$0.07, revenue of C$5.2M | 5 | Seeking Alpha | ||
| 19.11.24 | Medicure Inc (2): Medicure to release Q3 2024 results Nov. 15 | 2 | Stockwatch | ||
| 18.11.24 | Medicure, Inc.: Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member | 296 | ACCESS Newswire | WINNIPEG, MB / ACCESSWIRE / November 18, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals... ► Artikel lesen | |
| 18.11.24 | MEDICURE INC - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| 25.10.24 | Medicure Inc (2): Medicure receives 1.5M euros as dispute settlement | 1 | Stockwatch | ||
| 25.10.24 | Medicure, Inc.: Medicure Announces Positive Settlement of Product Development and Supply Contracts | 532 | ACCESS Newswire | WINNIPEG, MB / ACCESSWIRE / October 24, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and... ► Artikel lesen | |
| 14.08.24 | Medicure, Inc.: Medicure Announces Closing of Asset Purchase Agreement with Canam Bioresearch for Acquisition of Intellectual Property | 790 | ACCESS Newswire | WINNIPEG, MB / ACCESSWIRE / August 14, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and... ► Artikel lesen | |
| 14.08.24 | Medicure, Inc.: Medicure Reports Financial Results for Quarter Ended June 30, 2024 | 302 | ACCESS Newswire | WINNIPEG, ON / ACCESSWIRE / August 14, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and... ► Artikel lesen | |
| 24.06.24 | Medicure, Inc.: Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property | 396 | ACCESS Newswire | WINNIPEG, MB / ACCESSWIRE / June 24, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and... ► Artikel lesen | |
| 28.05.24 | Medicure, Inc.: Medicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results | 729 | ACCESS Newswire | WINNIPEG, MB / ACCESSWIRE / May 28, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare... ► Artikel lesen | |
| 23.04.24 | Medicure, Inc.: Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency | 633 | ACCESS Newswire | WINNIPEG, MB / ACCESSWIRE / April 23, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and... ► Artikel lesen | |
| 08.04.24 | Medicure, Inc.: Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023 | 443 | ACCESS Newswire | WINNIPEG, MB / ACCESSWIRE / April 8, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTCPINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare... ► Artikel lesen | |
| 05.04.24 | Medicure, Inc.: Medicure To Present Financial Results on April 9, 2024 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2023 | 741 | ACCESS Newswire | WINNIPEG, MB / ACCESSWIRE / April 4, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 86,52 | +0,82 % | Märkte am Morgen: Novo Nordisk, Hims & Hers, Berkshire, Applovin, Tesla, Just Eat, ProSiebenSat.1 | Bundestagswahl, Geschäftszahlen, Konjunkturdaten - der DAX hat heute und an den kommenden Tagen einige Themen zu verarbeiten. Die ersten Indikationen lassen auf einen positiven Start hoffen. Auch wenn... ► Artikel lesen | |
| PFIZER | 24,980 | -0,44 % | Pfizer: Pharma-Riese zieht die Reißleine | Keine guten Nachrichten vom US-amerikanischen Pharma-Giganten. Pfizer nimmt seine Gentherapie zur Behandlung der Hämophilie (Bluterkrankheit) vom Markt. Ein weiterer Rückschlag für das Unternehmen,... ► Artikel lesen | |
| GILEAD SCIENCES | 108,36 | +0,65 % | MEDSIR & Debiopharm Announce the First Patient Dosed in the WIN-B Trial Exploring the Combination of Debio 0123 & Gilead's Trodelvy in Advanced Breast Cancer | WIN-B (NCT06612203) is a Phase Ib/II, multi-center investigator-initiated trial, evaluating the safety and preliminary efficacy of combining Debiopharm's selective WEE1 inhibitor, Debio 0123 and... ► Artikel lesen | |
| AURORA CANNABIS | 4,880 | -1,33 % | Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain? | ||
| GSK | 17,980 | +0,36 % | GSK gibt Diversity-Ziele wegen Gegenwind auf | DJ GSK gibt Diversity-Ziele wegen Gegenwind auf
Von Adria Calatayud
DOW JONES--Der britische Pharmakonzern GSK hat angekündigt, seine Ziele für Diversität und Inklusion aufzugeben. Damit reiht... ► Artikel lesen | |
| ABBVIE | 197,84 | +0,48 % | AbbVie's Upadacitinib Gets Positive CHMP Opinion For Treatment Of Adults With Giant Cell Arteritis | WASHINGTON (dpa-AFX) - AbbVie (ABBV) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the approval... ► Artikel lesen | |
| CANOPY GROWTH | 1,372 | +1,18 % | Canopy Growth expands Tweed brand in Germany | ||
| ELI LILLY | 868,40 | -0,17 % | Pharma-Knaller: Eli Lillys neues Wundermittel - Ist Retatrutid das nächste Milliarden-Medikament | © Foto: Sascha Lotz/dpaEli Lillys neues Adipositas-Medikament Retatrutid sorgt für Aufsehen und treibt die Aktie des Unternehmens dank des boomenden Adipositas-Marktes in die Höhe!Laut einem Bericht... ► Artikel lesen | |
| TILRAY BRANDS | 0,710 | -2,63 % | Tilray Brands, Inc. - 8-K, Current Report | ||
| BRISTOL-MYERS SQUIBB | 56,54 | +0,11 % | Bristol-Myers Squibb Company (BMY): Top Stock to Buy from Dividend Stock Portfolio For Income | ||
| TEVA | 15,700 | 0,00 % | Teva Pharmaceutical Industries Ltd: Der Patient steht an erster Stelle: Warum Europa handeln muss, um den Zugang zu Arzneimitteln zu sichern | AMSTERDAM, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Laut einer neuen Studie von Teva Pharmaceuticals Europe werden 46 % der Generika auf der EU-Liste der kritischen Arzneimittel von nur einem Anbieter bereitgestellt.... ► Artikel lesen | |
| VERTEX PHARMACEUTICALS | 458,40 | +0,53 % | Vertex Pharmaceuticals Incorporated: Vertex Receives CHMP Positive Opinion for Expanded Label for KAFTRIO in Combination With Ivacaftor for People With Cystic Fibrosis to Include Rare Mutations | -If approved, approximately 4,000 people with cystic fibrosis in the European Union will be eligible for a medicine that treats the underlying cause of their disease for the first time- Vertex... ► Artikel lesen | |
| ABBOTT LABORATORIES | 130,58 | 0,00 % | Abbott: A Brighter Future for Employees With Student Loans | With all student loans now in repayment, Freedom 2 Save helps employees manage their loans and save for their future.Abbott NORTHAMPTON, MA / ACCESS Newswire / February 24, 2025 / When millions of Americans... ► Artikel lesen | |
| TAAT GLOBAL ALTERNATIVES | 0,169 | 0,00 % | TAAT Global Alternatives Inc (2): TAAT Global closes acquisition of Premium Products | ||
| MPH HEALTH CARE | 23,200 | +0,87 % | MPH Health Care Aktie: Finanzberichte neutral bewertet | Der Gesundheitsinvestor MPH Health Care AG verzeichnete am 21. Februar 2025 einen marginalen Kursrückgang von 0,43 Prozent auf 23,20 EUR. Die Aktie des Berliner Unternehmens zeigt sich dennoch in einer... ► Artikel lesen |
MEDICURE INC gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von -0,046 (-9,70 %) liegt der Kurs bei 0,428 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MEDICURE INC finden Sie auf Wallstreet Online.
